Molecular and Cellular Mechanisms of Sarcopenia: Integrating Fiber-Type Remodeling, Contractile Protein Dynamics, and Systemic Regulatory Pathways.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing molecular mechanisms without original human experimental data or systematic review methodology.
PubMed 41845891 · doi:10.1002/cbf.70194
What was done
This narrative review summarizes molecular and cellular pathways underlying sarcopenia. It examines the interplay between upstream systemic aging processes (telomere attrition, epigenetic remodeling, mitochondrial dysfunction, chronic low-grade inflammation, hormonal changes), satellite cell depletion, contractile protein composition (myosin heavy chains, titin, actin, troponin), and structural modulation by ankyrins and muscle ankyrin repeat proteins (MARPs).
What was found
The abstract reports no quantitative data or numerical outcomes. It describes mechanistic relationships, noting that age-related upstream factors drive preferential loss of fast-twitch (Type II) fibers, disrupted excitation-contraction coupling, increased proteolysis of contractile apparatus components, and dysregulation of ankyrin-contractile protein interactions, ultimately causing muscle weakness and structural instability.
Why it matters
It integrates sarcomeric protein dynamics and ankyrin-mediated mechanotransduction into a single mechanistic model of sarcopenia, outlining potential molecular targets and biomarkers for preserving muscle mass in older populations.
Limits
The paper provides no primary human or animal data and does not employ systematic review methods. No quantitative effect sizes, prevalence rates, or clinical efficacy measures are reported.
Cited by
- supports Type 2 fast-twitch muscle fibers atrophy and lose strength first during aging, before type 1 slow-twitch fibers.